Latest news with #SOD
Time of India
05-07-2025
- Business
- Time of India
Pune Metro line 3: First trial run conducted between Maan Depot and PMR04; 87% work completed; commercial operations to commence by March 2026
PUNE: A key step towards operational readiness, the Pune Metro Line 3 project, executed by the Pune Metropolitan Region Development Authority (PMRDA) conducted its first trial run on Friday, between Maan Depot and PMR04 station. The test run marks a significant milestone in the development of the city's third metro corridor, which has now achieved 87% completion, said, PMRDA officials on Friday post the trial run. Chief engineer of PMRDA Rinaj Pathan said the trial run focused on internal system checks and verification of Schedule of Dimensions (SOD) compliance across the viaduct and station infrastructure. "These assessments are essential for ensuring safety and functionality ahead of further testing phases and eventual passenger operations,"she told TOI. You Can Also Check: Pune AQI | Weather in Pune | Bank Holidays in Pune | Public Holidays in Pune The 23.3-km fully elevated metro line, being developed under a Public-Private Partnership (PPP) model by the Pune Metropolitan Region Development Authority (PMRDA) and Tata Group-led Pune IT City Metro Rail Ltd, will connect Hinjawadi IT Park with Shivajinagar. The project's Appointed Date was announced on November 25, 2021, with commercial operations expected to begin by March 2026, added officials. Designed to offer faster, safer, and greener transportation options, the corridor will comprise 23 stations and integrate with Pune's existing metro network through seamless interchanges. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo Four metro train sets manufactured by Alstom have already arrived in Pune. Each train includes three fully air-conditioned coaches with a total passenger capacity of approximately 1,000. The trains are designed to operate at speeds of up to 80 km/h, powered by a 750V DC third-rail system. The route will use advanced Communication-Based Train Control (CBTC) technology for improved safety and operational efficiency. Officials further added that the successful completion of the first trial run signals strong momentum for the project, which aims to decongest city roads and offer a reliable mass transit option to thousands of daily commuters.
Time of India
04-07-2025
- Business
- Time of India
First trial run of Pune Metro Line 3 conducted between Maan depot and Wipro Circle
Pune: The much-anticipated Pune Metro Line 3, which will connect Hinjawadi IT Park with Shivajinagar, achieved a key milestone on Friday with the successful completion of its first trial run. The trial was carried out between Maan Depot and PMR04 station (Wipro) as part of the project's internal system checks. The 23.3-km fully elevated corridor is being developed under public-private partnership (PPP) model by the Pune Metropolitan Region Development Authority (PMRDA) in collaboration with Tata Group-led Pune IT City Metro Rail Ltd. You Can Also Check: Pune AQI | Weather in Pune | Bank Holidays in Pune | Public Holidays in Pune As of July 4, the project has recorded 87% completion, marking a significant progress towards its target of commencing commercial operations by March 2026. The appointed date for the project was Nov 25, 2021, said Rinaj Pathan, chief superintending engineer, PMRDA. Friday's trial run focused on verifying Schedule of Dimensions (SOD) compliance along the viaduct and stations and conducting internal systems validation. Officials said the initial tests mark the beginning of an intensive phase of operational readiness and safety checks ahead of full-fledged trials. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với sàn môi giới tin cậy IC Markets Tìm hiểu thêm Undo "This trial run is a significant moment for the Pune Metro Line 3 project. It brings us closer to delivering a state-of-the-art, sustainable transport solution for Pune," said Pathan. The corridor will feature 23 stations and integrate with existing Pune Metro lines to offer seamless urban connectivity. It is expected to dramatically improve commute times, ease traffic congestion, and provide a safer and greener transport alternative for Pune's growing urban population. Four sleek, modern metro train sets supplied by global manufacturer Alstom have already arrived in the city. Each train comprises three fully air-conditioned coaches with a total carrying capacity of approximately 1,000 passengers. Designed for smooth and silent operation, the trains run on a 750V DC third-rail electrification system and can reach speeds of up to 80 km/h. The corridor will also be equipped with Communication-Based Train Control (CBTC) signaling technology, known for its high safety standards and efficient headway management. With a strategic route through the city's IT and business districts, the line is expected to benefit thousands of daily commuters, especially those working in the Hinjawadi Rajiv Gandhi Infotech Park. Urban mobility experts believe the completion of Pune Metro Line 3 will be a game-changer for the city's public transport network and will contribute to reducing vehicular emissions and road congestion in the long term.
Yahoo
30-04-2025
- Yahoo
Traffic stop in Duplin County ends in drug trafficking arrest
DUPLIN COUNTY, N.C. (WNCT) — Officials with the Duplin County Sheriff's Office arrested a man after a traffic stop for trafficking large amounts of drugs. On Thursday, Apr. 10, 2025, the Duplin County Sheriff's Office Special Operations Division (SOD) conducted a traffic stop in the Warsaw area of Duplin County. The vehicle was being operated by Daniel Walter England III. England fled on foot after jumping out of the vehicle. While running, he threw large amounts of drugs and cash on the ground. He was arrested by officials and sent to the Duplin County Jail. England was charged with: Trafficking Opium or Heroin (3 Felony Counts). Trafficking Methamphetamine (3 Felony Counts). Possession With Intent to Manufacture Sell Deliver Schedule II Controlled Substance Fentanyl (1 Felony Count). Possession With Intent to Manufacture Sell Deliver Schedule II Controlled Substance Methamphetamine (1 Felony Count). Possession With Intent to Manufacture Sell Deliver Schedule II Controlled Substance Cocaine (1 Felony Count). Simple Possession of Schedule VI Marijuana (1 Count Misdemeanor). Flee/Elude Arrest with Motor Vehicle (1 Felony Count). Resisting Public Officer (1 Count Misdemeanor). Assault Government Official/Employee (1 Count Misdemeanor). Possession Drug Paraphernalia (1 Count Misdemeanor). Possession Marijuana Paraphernalia (1 Count Misdemeanor). Injury To Personal Property (1 Count Misdemeanor). England was placed under a $1,100,000 secured bond at the Duplin County Jail. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Korea Herald
20-02-2025
- Business
- Korea Herald
Merck showcases AI chip materials platform at Semicon Korea 2025
German technology firm Merck showcased its new artificial intelligence-driven chip materials platform, which has impressively reduced research and development time for critical materials used in advanced chips, at this year's Semicon Korea, Thursday. 'Without materials, AI wouldn't be possible. To power AI, we need powerful, compact and energy efficient chips, which increases complexity in both chip architecture and manufacturing processes," said Anand Nambiar, chief commercial officer of Merck Electronics, during a press conference held on the sidelines of Semicon Korea 2025, running from Wednesday to Friday in Seoul. "This is where materials solutions can play a critical role in addressing the physical and economic challenges faced by chipmakers." According to Nambiar, Merck's Materials Intelligence platform has enabled the company's researchers to run simulations instead of physical experiments to effectively reduce the time needed for its basic chemistry research. "We're learning how data digitalization is helping us answer some of the challenges that we've faced for decades," the CCO said. As demand is rising for advanced AI chips, Merck is working to converge material science with AI to develop new solutions for AI-enabling technologies, including Gate All-Around, high-density memory and HBM chips. This year, the company will also focus on facility investment, especially on thin-film materials and specialty gases. Regarding the impact of the second-term of the Trump administration, Nambiar acknowledged there may be "a little transition" as governments, including the US and Japan, are introducing measures to bring chip manufacturing onto their soil. "Asia still represents 80 percent of semiconductor capacity. Korea and Taiwan are leading countries where capacity is installed, and leading edge customers are present," Nambiar said. During the three-day Semicon event, Merck focused on materials for advanced logic and 3D densification in DRAM and 3D NAND memory chips. This includes enhanced features in Atomic Layer Deposition for advanced nodes, spin-on dielectrics (SOD) materials for gap fill technology and organometallics solutions for FinFet-architecture DRAM, among others. "We have been an innovation partner to our Korean customers for 36 years, and we are committed to supporting their future growth. This includes the recently inaugurated Korea SOD Application Center in Anseong, announced last year, and ongoing investments in new product lines at the Eumseong site," said Kim Woo-kyu, managing director of Merck Korea. "We will continue to fulfill our investment commitment to enhance our local capability and capacity for faster and more responsive support and services." The Germany-based chemical materials firm entered the Korean market in 1989, and now operates 13 production and R&D sites with over 1,700 employees, making Korea its second-largest business hub after the US.
Associated Press
11-02-2025
- Business
- Associated Press
Cellev8 Nutrition(TM) and NFL Legend Andre Reed Launch Groundbreaking Partnership at Super Bowl, Revolutionizing Cellular Health in Sports
Cellev8 Continues to breakthrough, enhance and improve the lives of athletes globally WELLINGTON, FL / ACCESS Newswire / February 11, 2025 / Innovative Wellness Company Teams Up with Hall of Famer to Transform Athletic Performance and Recovery - In a spectacular event that coincided with one of the biggest sports spectacles of the year, Cellev8 Nutrition Inc. (OTC PINK:CELV) and Pro Football Hall of Fame wide receiver Andre Reed have officially launched their highly anticipated partnership at this year's Super Bowl. This collaboration marks a new era in athlete health optimization, leveraging Cellev8's cutting-edge cellular health technology and Reed's legendary status in professional football. Pioneering Cellular Health Solutions Cellev8 Nutrition has emerged as a leader in advanced natural supplements, focusing on the scientifically proven benefits of Superoxide Dismutase (SOD), the body's most powerful antioxidant. The company's groundbreaking patent-pending technology utilizes soluble fiber-enhanced gummies to deliver approximately 140 or more units of SOD2 daily, achieving near-complete delivery and absorption of this vital enzyme in the small intestine. 'Our proprietary delivery system is a game-changer in the supplement industry,' said Michael Ferraro, CEO of Cellev8 Nutrition. 'By protecting SOD and other powerful ingredients from the digestive tract, we're able to maximize their effectiveness in the body, offering unparalleled support for cellular health, recovery, and overall wellness.' A Partnership Forged in Excellence Andre Reed, known for his illustrious career with the Buffalo Bills, brings his passion for peak performance to this partnership. 'Teaming up with Cellev8™ is about more than just endorsing a product,' Reed stated. 'It's about introducing a new standard of health and recovery to athletes at all levels. These products have the potential to extend careers and enhance quality of life long after the game ends. 'The partnership launch at the Super Bowl generated unprecedented exposure for Cellev8™. Ferraro elaborated on the success: 'This epic launch generated enormous amounts of exposure for Cellev8 and our products. Andre and his wife Theresa took the bull by the horns and introduced us to the most influential players and Hall of Famers, like Cam Newton, Mike Singletary, Doug Flutie, Alexander Mattison, Bobby Okereke, Drew Brees, Terrell Davis, Steve Smith Sr, and many, many more. Andre was interviewed by well over a dozen podcasts, radio shows, TV shows, and social media outlets, not only talking about Andre but letting the world know about the benefits of Cellev8's™ products first-hand.' This coupled with over 40 professional and collegiate teams currently purchasing the product for their athletes and staff marks the beginning of what could be the next mega-brand for wellness in and out of sports. Revolutionary Product Line Cellev8's product range includes: Cellular Benefits: The Cellev8 Advantage Cellev8's innovative formulations offer a range of cellular benefits that significantly impact overall health and wellness: Cellular Protection and Repair: SOD eliminates free radicals at an impressive ratio of around 1,000,000 to 1, providing unparalleled protection against oxidative stress and supporting cellular repair. Enhanced Mitochondrial Function: SOD2, located in the mitochondria, helps maintain optimal energy production within cells, potentially leading to improved overall energy levels. Reduced Inflammation: The combination of SOD and other antioxidants helps reduce cellular inflammation, promoting faster recovery from physical exertion. Optimized Cellular Function: Cellev8's™ unique delivery system ensures that beneficial compounds reach their intended destinations in the body, enhancing nutrient delivery and creating an optimal cellular environment. Long-Term Cellular Health: Regular use of Cellev8's™ products may contribute to slowed cellular aging and improved cellular resilience against various stressors. Key Differentiators in Sports Nutrition Cellev8's™ products stand out in the crowded sports nutrition market due to several unique features: Proprietary SOD Delivery System: The patent-pending soluble fiber-enhanced gummy technology ensures optimal absorption of SOD2, addressing a long-standing challenge in supplement efficacy. Focus on Cellular Health: By targeting mitochondrial function and overall cellular wellness, Cellev8™ addresses the fundamental aspects of athletic performance and recovery. Comprehensive Antioxidant Complex: The synergistic blend of SOD2 and other antioxidants provides a more holistic approach to combating oxidative stress. Targeted Product Range: Each product in the Cellev8™ line addresses specific needs, from weight management to cognitive enhancement and inflammation reduction. Clinically Tested Ingredients: The use of validated formulations like Melorun® in the upcoming Elev8™ product underscores Cellev8's™ commitment to scientific rigor. Multi-functional Benefits: Beyond performance enhancement, Cellev8's™ products offer improvements in sleep quality, detoxification support, and long-term wellness. Convenient Gummy Format: The palatable gummy form factor provides a more enjoyable and convenient supplement experience compared to traditional pills or powders. Market Opportunity and Growth Potential The partnership between Cellev8™ and Andre Reed comes at a time of significant growth in the wellness supplements and gummy markets: The global wellness supplements market size was estimated at $270.12 billion in 2024 and is anticipated to reach around $568.75 billion by 2034, expanding at a CAGR of 7.73% from 2025 to 2034. The nutritional supplements market is projected to grow from $444.98 billion in 2025 to $617.6 billion in 2029 at a CAGR of 8.5%. The global gummy market was valued at USD 23.93 billion in 2023 and is expected to grow at a CAGR of 11.8% from 2024 to 2030. The global gummy supplements market is estimated to reach USD 10.89 billion in 2025 and is projected to grow at a CAGR of 7.83% to reach USD 15.88 billion by 2030. The global gummy vitamins market is projected to generate revenue of USD 4.36 billion in 2024 and is expected to reach USD 7.18 billion by the end of 2034, growing at a CAGR of 5.1% from 2024 to 2034. These figures underscore the immense potential for Cellev8'™s innovative products in the rapidly expanding wellness and gummy supplement markets. The company is well-positioned to capitalize on the growing consumer demand for convenient, effective, and enjoyable supplement options. Impact on the Sports Community and Future Endeavors The launch of this partnership at the Super Bowl underscores its significance and potential impact on the sports community. Both Cellev8™ and Andre Reed believe that their combined efforts will inspire athletes at all levels to prioritize their health and adopt advanced wellness practices. Looking ahead, Cellev8™ and Andre Reed plan to introduce a series of initiatives aimed at educating athletes and the broader community about the benefits of cellular health. These initiatives will include workshops, seminars, and the development of tailored products that cater specifically to the needs of sports professionals. 'The exposure was amazing, and I feel the company will not only add more product users but also establish more relationships in the NFL and with people connected to sports,' Ferraro added. 'This is just the beginning of our mission to revolutionize cellular health and wellness in sports. 'As Cellev8™ and Andre Reed embark on this exciting journey, they invite athletes, sports enthusiasts, and health-conscious individuals to experience the next level of cellular health and discover the Cellev8™ difference. For more information about Cellev8 Nutrition™ and its innovative product line, visit About Cellev8 Nutrition Inc.™ Cellev8 Nutrition Inc.™ (OTC PINK:CELV) is a pioneer in SOD-based supplements, dedicated to enhancing wellness and promoting health from the cellular level. Through advanced formulations and delivery mechanisms, Cellev8™ is setting new standards in the nutraceutical industry. Cellev8 is the first company known for successfully delivering SOD and other key ingredients to assist the body's overall performance via gummies, allowing maximum effectiveness in the body. CEO 561-578-0000 SOURCE: Cellev8 Nutrition Inc.
